Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing for breast-ovarian cancer susceptibility: a regional trial.

Genetic testing - 1 Jan 1998

Loader S, Levenkron J C, Rowley P T

Abstract excerpt

To evaluate receptivity to testing for a genetic susceptibility to breast-ovarian cancer, information is needed on the response when the offer is open to all qualifying women in a given region. To qualify in this trial, a woman who had not had breast or ovarian cancer had to have at least two first-degree relatives or one first- and one second-degree relative with breast and/or ovarian cancer, whereas a woman who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Genes, BRCA1
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to New York

Share to Ovarian Neoplasms

Share to Patient Acceptance of Health Care

Share to Patient Education as Topic

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 10464609
DOI: 10.1089/gte.1998.2.305

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing for breast-ovarian cancer susceptibility: a regional trial.PMID 10464609Read ↗

'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.Semantic proximity Read ↗

Impact of genetic testing for breast-ovarian cancer susceptibility.Semantic proximity Read ↗

Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibilitySemantic proximity Read ↗

Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition.Semantic proximity Read ↗

Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providersSemantic proximity Read ↗

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.Semantic proximity Read ↗

Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.Semantic proximity Read ↗

Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.Semantic proximity Read ↗

Factors Associated with an Individual's Decision to Withdraw from Genetic Testing for Breast And Ovarian Cancer Susceptibility: Implications for CounselingSemantic proximity Read ↗

[Attitudes towards screening and prevention of breast and ovarian cancers with hereditary predisposition. Survey by female gynecologists in the north of France].Semantic proximity Read ↗

Cancer genetics--survey of primary care physicians' attitudes and practices.Semantic proximity Read ↗

Genetic testing for breast cancer susceptibility: Polish women's attitudes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.